---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-025955"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2023-07-27T23:59:59+00:00"
generated_at: "2026-06-13T00:47:27.419849+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# GoodRx CMO Babak Azad departs; separation deal includes $205K lump sum, equity vest

## Summary
- Azad's last day as CMO was July 7, 2023; separation agreement entered July 26, 2023.
- Lump sum payment of $205,000; immediate vesting of 50,000 option shares and 20,402 RSUs.
- Option exercise extended to 6 months post-separation; COBRA premium reimbursement for 9 months.
- Mutual non-disparagement and full release of claims; agreement effective Aug 2, 2023 if not revoked.

## SEC filing metadata
- accession: 0001628280-23-025955
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2023-07-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000162828023025955/0001628280-23-025955-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000162828023025955/gdrx-20230726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-025955
- JSON: https://secwatch.observer/filing/0001628280-23-025955.json
- Plain text: https://secwatch.observer/filing/0001628280-23-025955.txt

## Key facts
- Executive change
  Babak Azad departed as Chief Marketing Officer at GoodRx Holdings, Inc..
  - Action: departed
  - Role: Chief Marketing Officer
  source text: As previously disclosed, on June 27, 2023, GoodRx Holdings, Inc. (the “ Company ”) determined that Babak Azad would no longer serve as Chief Marketing Officer and SVP, Marketing & Communications of the Company, effective July 7, 2023 (the “ Separation Date ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000162828023025955/0001628280-23-025955-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.